Authors:
SZENTPALI K
SZENDRENYI V
OLAH T
LAZAR T
BALOGH A
Citation: K. Szentpali et al., EFFECTIVITY OF ENDOSCOPIC ESOPHAGEAL INTUBATION IN THE PALLIATION FORADVANCED, ESOPHAGUS CANCERS, British Journal of Surgery, 85, 1998, pp. 184-184
Authors:
SCIBERRAS DG
POLVINO WJ
GERTZ BJ
CHENG HY
STEPANAVAGE M
WITTREICH J
OLAH T
EDWARDS M
MANT T
Citation: Dg. Sciberras et al., INITIAL HUMAN-EXPERIENCE WITH MK-462 (RIZATRIPTAN) - A NOVEL 5-HTID AGONIST (VOL 43, PG 49, 1997), British journal of clinical pharmacology, 43(4), 1997, pp. 450-450
Authors:
SCIBERRAS DG
POLVINO WJ
GERTZ BJ
CHENG HY
STEPANAVAGE M
WITTREICH J
OLAH T
EDWARDS M
MANT T
Citation: Dg. Sciberras et al., INITIAL HUMAN-EXPERIENCE WITH MK-462 (RIZATRIPTAN) - A NOVEL 5-HT1D AGONIST, British journal of clinical pharmacology, 43(1), 1997, pp. 49-54
Citation: T. Olah et al., THE INHIBITORY EFFECTS OF ALLOPURINOL ON THE PRODUCTION AND CYTOTOXICITY OF TUMOR-NECROSIS-FACTOR, Naunyn-Schmiedeberg's archives of pharmacology, 350(1), 1994, pp. 96-99
Authors:
POLVINO W
SCIBERRAS D
GERTZ B
CHENG H
STEPANAVAGE M
WITTREICH J
OLAH T
EDWARDS M
MANT T
Citation: W. Polvino et al., MK-462 - 1ST HUMAN-EXPERIENCE WITH A NOVEL 5-HT1D AGONIST, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 129-129